ReviewOpen Access
Disorders of carnitine transport and the carnitine cycle
Author Affiliations
University of Utah, Bangladesh Institute of Research and Rehabilitation for Diabetes Endocrine and Metabolic Disorders, Associação de Assistência à Criança Deficiente, ARUP Laboratories (United States)
Published InAmerican Journal of Medical Genetics Part C Seminars in Medical Genetics
Year2006
Citations540
Abstract
Carnitine plays an essential role in the transfer of long-chain fatty acids across the inner mitochondrial membrane. This transfer requires enzymes and transporters that accumulate carnitine within the cell (OCTN2 carnitine transporter), conjugate it with long chain fatty acids (carnitine palmitoyl transferase 1, CPT1), transfer the acylcarnitine across the inner plasma membrane (carnitine-acylcarnitine translocase, CACT), and conjugate the fatty acid back to Coenzyme A for subsequent beta oxidation (carnitine palmitoyl transferase 2, CPT2). Deficiency of the OCTN2 carnitine transporter causes primary carnitine deficiency, characterized by increased losses of carnitine in the urine and decreased carnitine accumulation in tissues. Patients can present with hypoketotic hypoglycemia and hepatic encephalopathy, or with skeletal and cardiac myopathy. This disease responds to carnitine supplementation. Defects…
View at Publisher
BORR does not host full-text PDFs. The button above takes you to the original publisher.